Global Medical REIT Inc. Stock

Equities

GMRE

US37954A2042

Specialized REITs

Market Closed - Nyse 16:00:02 2024-06-21 EDT 5-day change 1st Jan Change
8.81 USD -2.54% Intraday chart for Global Medical REIT Inc. -2.33% -20.63%
Sales 2024 * 139M 190M Sales 2025 * 146M 199M Capitalization 607M 831M
Net income 2024 * 1M 1.37M Net income 2025 * 3M 4.11M EV / Sales 2024 * 4.36 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 4.17 x
P/E ratio 2024 *
411 x
P/E ratio 2025 *
146 x
Employees 26
Yield 2024 *
9.08%
Yield 2025 *
9.24%
Free-Float 94.24%
More Fundamentals * Assessed data
Dynamic Chart
Global Medical REIT Keeps Q2 Dividend at $0.21 a Share, Payable July 9 to Holders of Record June 21 MT
Global Medical REIT Inc. Declares 2024 Second Quarter Common Dividend, Payable on July 9, 2024 CI
B. Riley Securities Adjusts Global Medical REIT's Price Target to $10 From $11, Keeps Buy Rating MT
Transcript : Global Medical REIT Inc., Q1 2024 Earnings Call, May 08, 2024
Earnings Flash (GMRE) GLOBAL MEDICAL REIT Reports Q1 Revenue $35.1M MT
Global Medical REIT Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Global Medical REIT Inc. entered into a purchase agreement to acquire 15-property portfolio of outpatient medical real estate for $81.3 million. CI
Global Medical REIT Keeps Quarterly Dividend at $0.21 Per Share, Payable April 9 to Shareholders on March 22 MT
Global Medical REIT Inc. Declares Cash Dividend for the First Quarter 2024, Payable on April 9, 2024 CI
Transcript : Global Medical REIT Inc., Q4 2023 Earnings Call, Feb 28, 2024
Global Medical REIT Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Earnings Flash (GMRE) GLOBAL MEDICAL REIT Reports Q4 Revenue $33M MT
Global Medical REIT Maintains Quarterly Dividend at $0.21 a Share, Payable Jan. 9 to Shareholders as of Dec. 27 MT
Global Medical REIT Inc. Declares 2023 Fourth Quarter Common Stock Dividend, Payable on January 9, 2024 CI
Transcript : Global Medical REIT Inc., Q3 2023 Earnings Call, Nov 07, 2023
More news
1 day-2.54%
1 week-2.33%
Current month-5.17%
1 month-0.79%
3 months+1.61%
6 months-22.24%
Current year-20.63%
More quotes
1 week
8.77
Extreme 8.77
9.27
1 month
8.56
Extreme 8.56
9.41
Current year
7.98
Extreme 7.98
11.12
1 year
7.98
Extreme 7.98
11.59
3 years
7.01
Extreme 7.01
18.51
5 years
6.98
Extreme 6.98
18.51
10 years
0.13
Extreme 0.125
130.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 14-09-29
Director of Finance/CFO 58 17-08-22
Chief Operating Officer 51 16-03-29
Members of the board TitleAgeSince
Chief Executive Officer 66 14-09-29
Director/Board Member 81 15-08-18
Director/Board Member 64 18-04-30
More insiders
Date Price Change Volume
24-06-21 8.81 -2.54% 626 529
24-06-20 9.25 +0.33% 315,045
24-06-18 9.22 +1.54% 358,446
24-06-17 9.08 +0.67% 293,447
24-06-14 9.02 -1.10% 311,468

Delayed Quote Nyse, June 21, 2024 at 04:00 pm

More quotes
Global Medical REIT Inc. is an internally managed real estate investment trust (REIT). The Company acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems. The Company conducts its business through a wholly owned subsidiaries of its operating partnership, Global Medical REIT L.P. It owns 92.91% of the outstanding common operating partnership units (OP Units) of its operating partnership, with an aggregate of 7.09% of the Operating Partnership owned by holders of long-term incentive plan units (LTIP Units) and third-party limited partners who contributed properties or services to the operating partnership in exchange for OP Units. Its portfolio includes medical office buildings (MOBs), inpatient rehab. facility (IRF), surgical hospital and others. The Company's portfolio is located in various areas, including Texas, Florida, Ohio, Oklahoma, Pennsylvania, Arizona, and Illinois.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
9.25 USD
Average target price
10.29 USD
Spread / Average Target
+11.26%
Consensus